These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 28501028)

  • 21. Episodic fevers and vasodilatory shock mimicking urosepsis in a patient with HIV-associated multicentric Castleman's Disease: a case report.
    Anderson S; Sasson SC; Lee FJ; Cooper W; Larsen S; Garsia R
    BMC Infect Dis; 2016 Feb; 16():53. PubMed ID: 26831502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Castleman disease: the great mimic.
    Bonekamp D; Horton KM; Hruban RH; Fishman EK
    Radiographics; 2011 Oct; 31(6):1793-807. PubMed ID: 21997995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schnitzler syndrome co-occurring with idiopathic multicentric Castleman disease that responds to anti-IL-1 therapy: A case report and clue to pathophysiology.
    Soudet S; Fajgenbaum D; Delattre C; Forestier A; Hachulla E; Hatron PY; Launay D; Terriou L
    Curr Res Transl Med; 2018 Sep; 66(3):83-86. PubMed ID: 30108026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unicentric Castleman Disease: A Rare Diagnosis of Radiological and Histological Correlation.
    Maqbool S; Javed A; Idrees T; Anwar S
    Indian J Otolaryngol Head Neck Surg; 2023 Jun; 75(2):975-978. PubMed ID: 36373120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicentric Castleman Disease with Monoclonal Incomplete IgH Restriction: A Rare Coexistence.
    Goyal G; Kendric K; Silberstein PT; Caponetti GC; Vivekanandan R
    J Clin Exp Hematop; 2015; 55(2):103-8. PubMed ID: 26490523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathology of Castleman Disease.
    Wu D; Lim MS; Jaffe ES
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):37-52. PubMed ID: 29157618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical behavior of localized and multicentric Castleman disease.
    Herrada J; Cabanillas F; Rice L; Manning J; Pugh W
    Ann Intern Med; 1998 Apr; 128(8):657-62. PubMed ID: 9537940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful rituximab treatment of an elderly Japanese patient with HHV8-positive, HIV-negative multicentric Castleman disease.
    Kaga H; Kurahashi H; Kubota A; Hatano Y; Nanjo H; Wakui H; Takahashi N
    Int J Hematol; 2022 Jan; 115(1):129-134. PubMed ID: 34591291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HHV-8-Associated Multicentric Castleman Disease, a Diagnostic Challenge in a Patient With Acquired Immunodeficiency Syndrome and Fever.
    Dunn R; Jariwal R; Venter F; Mishra S; Bhandohal J; Cobos E; Heidari A
    J Investig Med High Impact Case Rep; 2022; 10():23247096221097526. PubMed ID: 35549932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The heterogeneity of Castleman disease: report of five cases and review of the literature.
    Maslovsky I; Uriev L; Lugassy G
    Am J Med Sci; 2000 Oct; 320(4):292-5. PubMed ID: 11061358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicentric Castleman disease: Where are we now?
    Wang HW; Pittaluga S; Jaffe ES
    Semin Diagn Pathol; 2016 Sep; 33(5):294-306. PubMed ID: 27296355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unicentric Castleman Disease.
    Wong RSM
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):65-73. PubMed ID: 29157620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Historical and pathological overview of Castleman disease.
    Nishimura MF; Nishimura Y; Nishikori A; Yoshino T; Sato Y
    J Clin Exp Hematop; 2022 Jun; 62(2):60-72. PubMed ID: 35474035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fever and generalised lymphadenopathy in an HIV-positive patient: a diagnostic challenge.
    Neves B; Raimundo P; Farinha P
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28814592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic lupus erythematosus complicated with Castleman disease: a case-based review.
    Demirkan FG; Doğan S; Kalyoncu Uçar A; Sönmez HE; Aktay Ayaz N
    Rheumatol Int; 2021 Feb; 41(2):475-479. PubMed ID: 32797278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgG4-related Disease Involving Multiple Organs with Elevated Serum Interleukin-6 Levels.
    Ikeura T; Horitani S; Masuda M; Kasai T; Yanagawa M; Miyoshi H; Uchida K; Takaoka M; Miyasaka C; Uemura Y; Okazaki K
    Intern Med; 2016; 55(18):2623-8. PubMed ID: 27629957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids: Case report.
    Cai S; Zhong Z; Li X; Wang HX; Wang L; Zhang M
    Medicine (Baltimore); 2019 Nov; 98(46):e17681. PubMed ID: 31725610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of hypercalcemia associated with Castleman disease.
    Washington T; Vora A; Mihailescu D
    Endocr Pract; 2010; 16(6):1007-11. PubMed ID: 21041171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicentric IL-5-positive Castleman Disease With Nephrotic Syndrome Relapsed After Rituximab Treatment.
    Mima A; Lee R; Murakami A; Gotoda H; Akai R; Lee S
    In Vivo; 2023; 37(1):493-497. PubMed ID: 36593046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy.
    Chronowski GM; Ha CS; Wilder RB; Cabanillas F; Manning J; Cox JD
    Cancer; 2001 Aug; 92(3):670-6. PubMed ID: 11505414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.